|
|
Volumn 26, Issue 8, 2010, Pages 599-601
|
|
Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: Evidence from mouse models
|
|
Author keywords
Cancer development; Endogenous hyperinsulinaemia; Type 2 diabetes
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CYTOKINE;
GLUCOSE;
INSULIN;
INSULIN GLARGINE;
INSULIN RECEPTOR;
INSULIN RECEPTOR A;
INSULIN RECEPTOR B;
LEPTIN;
METFORMIN;
PROTEIN TYROSINE KINASE INHIBITOR;
SOMATOMEDIN C;
SOMATOMEDIN C RECEPTOR;
UNCLASSIFIED DRUG;
BREAST CANCER;
BREAST CARCINOGENESIS;
CANCER GROWTH;
CANCER MORTALITY;
CANCER RISK;
DISEASE ASSOCIATION;
GLYCOLYSIS;
HUMAN;
HYPERINSULINEMIA;
HYPERLIPIDEMIA;
INSULIN BLOOD LEVEL;
LUNG METASTASIS;
MOUSE STRAIN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
REVIEW;
RISK REDUCTION;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
DISEASE MODELS, ANIMAL;
FEMALE;
HYPERINSULINISM;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
NEOPLASMS;
OBESITY;
RECEPTOR, INSULIN;
RISK FACTORS;
|
|
EID: 78049470371
PISSN: 15207552
EISSN: 15207560
Source Type: Journal
DOI: 10.1002/dmrr.1139 Document Type: Review |
|
Times cited : (18)
|
|
References (4)
|
